(Q38400624)

2 September 2017

1 reference

title

Lipodystrophies: adipose tissue disorders with severe metabolic implications (English)

1 reference

2 September 2017

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25833179%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

author name string

Marta Fernández-Galilea

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25833179%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

language of work or name

1 reference

2 April 2015

1 reference

Journal of Physiology and Biochemistry

2 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25833179%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

volume

71

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25833179%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25833179%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

page(s)

471-478

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25833179%20AND%20SRC:MED&resulttype=core&format=json

Role of A-type lamins in signaling, transcription, and chromatin organization.

8 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0404-1

An undiagnosed endocrinometabolic syndrome: report of 2 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0404-1

Nuclear lamin A/C R482Q mutation in canadian kindreds with Dunnigan-type familial partial lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0404-1

Efficacy of leptin therapy in the different forms of human lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0404-1

Identification of a novel mitochondrial protein (“mitoNEET”) cross-linked specifically by a thiazolidinedione photoprobe

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0404-1

Leptin ameliorates insulin resistance and hepatic steatosis in Agpat2-/- lipodystrophic mice independent of hepatocyte leptin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0404-1

Divergent metabolic phenotype between two sisters with congenital generalized lipodystrophy due to double AGPAT2 homozygous mutations. a clinical, genetic and in silico study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0404-1

Effect of diet intervention and oral zinc supplementation on metabolic control in Berardinelli-Seip syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0404-1

New metabolic phenotypes in laminopathies: LMNA mutations in patients with severe metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0404-1

Effects of switching from stavudine to raltegravir on subcutaneous adipose tissue in HIV-infected patients with HIV/HAART-associated lipodystrophy syndrome (HALS). A clinical and molecular study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0404-1

Efficacy and safety of leptin-replacement therapy and possible mechanisms of leptin actions in patients with generalized lipodystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0404-1

Perilipin deficiency and autosomal dominant partial lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0404-1

Clinical review#: Lipodystrophies: genetic and acquired body fat disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0404-1

Köbberling type of familial partial lipodystrophy: an underrecognized syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0404-1

Long-term efficacy of leptin replacement in patients with generalized lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0404-1

Proteinuric nephropathy in acquired and congenital generalized lipodystrophy: baseline characteristics and course during recombinant leptin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0404-1

Taking the lymphatic route: dendritic cell migration to draining lymph nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0404-1

Pregnancy in a woman with congenital generalized lipodystrophy: leptin's vital role in reproduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0404-1

Effects of exogenous leptin on satiety and satiation in patients with lipodystrophy and leptin insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0404-1

Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0404-1

Clinical features and metabolic derangements in acquired generalized lipodystrophy: case reports and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0404-1

Clinical features and metabolic and autoimmune derangements in acquired partial lipodystrophy: report of 35 cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0404-1

Leptin activates hepatic 5'-AMP-activated protein kinase through sympathetic nervous system and α1-adrenergic receptor: a potential mechanism for improvement of fatty liver in lipodystrophy by leptin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0404-1

Triglyceride-induced diabetes mellitus in congenital generalized lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0404-1

Spectrum of renal diseases associated with extreme forms of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0404-1

Back to the future: the Mediterranean diet paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0404-1

Leptin-replacement therapy for lipodystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0404-1

FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0404-1

Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0404-1

Novel forms of lipodystrophy: why should we care?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0404-1

The renal lesion associated with total lipodystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0404-1

Congenital generalized lipodystrophy, type 4 (CGL4) associated with myopathy due to novel PTRF mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0404-1

Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0404-1

Prolonged thiazolidinedione therapy does not reverse fat loss in patients with familial partial lipodystrophy, Dunnigan variety

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0404-1

Effect of leptin replacement on intrahepatic and intramyocellular lipid content in patients with generalized lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0404-1

Type 2 diabetes with partial lipodystrophy of the limbs: a new lipodystrophy phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0404-1

Overlapping syndrome with familial partial lipodystrophy, Dunnigan variety and cardiomyopathy due to amino-terminal heterozygous missense lamin A/C mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0404-1

Brown adipose tissue: mechanisms and potential therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0404-1

Adherence to Mediterranean diet is favorably associated with metabolic parameters in HIV-positive patients with the highly active antiretroviral therapy-induced metabolic syndrome and lipodystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0404-1

Adherence to the Mediterranean diet is associated with a lower risk of body-shape changes in Croatian patients treated with combination antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0404-1

Gluttony, sloth and the metabolic syndrome: a roadmap to lipotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0404-1

Insulin resistance in limb and trunk partial lipodystrophy (type 2 Köbberling-Dunnigan syndrome).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0404-1

Lipodystrophy associated with highly active anti-retroviral therapy for HIV infection: the adipocyte as a target of anti-retroviral-induced mitochondrial toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0404-1

Characterisation of non-obese diabetic patients with marked insulin resistance identifies a novel familial partial lipodystrophy-associated PPARγ mutation (Y151C).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0404-1

Increased oxidative stress impairs adipose tissue function in sphingomyelin synthase 1 null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0404-1

High prevalence of laminopathies among patients with metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0404-1

Dilated cardiomyopathy and myocardial infarction secondary to congenital generalized lipodystrophy.

21 January 2018

1 reference

12 December 2020

[Novel physiological and therapeutic implications of leptin]

1 reference

12 December 2020

Inflammasomes and the microbiota--partners in the preservation of mucosal homeostasis

1 reference

12 December 2020

Familial lipoatrophic diabetes with dominant transmission. A new syndrome.

1 reference

12 December 2020

A novel heterozygous mutation in peroxisome proliferator-activated receptor-gamma gene in a patient with familial partial lipodystrophy

1 reference

12 December 2020

Lipodystrophy of the extremities. A dominantly inherited syndrome associated with lipatrophic diabetes

1 reference

12 December 2020

Total lipodystrophy with heart failure and renal failure: report of a case

1 reference

12 December 2020

Successful renal transplantation in a patient with congenital generalized lipodystrophy: a case report

1 reference

12 December 2020

Lipodystrophy and gigantism with associated endocrine manifestations. A new diencephalic syndrome?

1 reference

12 December 2020

Site and mechanism of leptin action in a rodent form of congenital lipodystrophy

1 reference

12 December 2020

The adipocyte as an endocrine cell

1 reference

12 December 2020